PBH Company Profile and Key Details

Q: Who are the executives of PBH?

Ms. Christine SaccoChief Financial OfficerMr. Adel MekhailExecutive Vice President of Marketing & SalesMs. Mary Beth FritzSenior Vice President of Quality & Regulatory AffairsMr. Ronald M. LombardiChairman, Pres & Chief Executive OfficerMr. Philip David TerpolilliDirector of Investor RelationsMr. William C. P'PoolSenior Vice President, Gen. Counsel & Corporation Sec.Mr. Jeffrey ZerilloSenior Vice President of OperationsDean SiegalDirector of Communications

NYSE : PBH

Prestige Consumer Healthcare

$65.55

-1.48-2.21%

At Close 4:00 PM

66.32

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Prestige Consumer Healthcare Inc. (PBH) stock declined over -2.21%, trading at $65.55 on NYSE, down from the previous close of $67.03. The stock opened at $64.09, fluctuating between $63.70 and $68.62 in the recent session.

Stock Snapshot

67.03

Prev. Close

3.15B

Market Cap

63.7

Day Low

16.59

P/E Ratio

3.95

EPS (TTM)

4.63

Cash Flow per Share

64.09

Open

48.08M

Number of Shares

68.62

Day High

99.33%

Free Float in %

31.93

Book Value

560.88K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	64.09	68.62	63.69	65.55	633.21K
Feb 04, 2026	64.01	67.99	64.01	67.03	649.52K
Feb 03, 2026	64.42	65.63	64.00	64.43	507.18K
Feb 02, 2026	64.15	66.01	63.97	65.44	351.33K
Jan 30, 2026	63.96	64.95	63.35	64.47	406.66K
Jan 29, 2026	63.05	64.26	62.73	63.90	378.28K
Jan 28, 2026	63.92	64.12	63.11	63.15	321.18K
Jan 27, 2026	65.20	65.51	63.20	63.90	315.92K
Jan 26, 2026	65.80	66.14	65.05	65.66	360.84K
Jan 23, 2026	67.56	67.71	65.65	65.80	367.23K
Jan 22, 2026	66.88	68.28	66.76	67.73	376.81K
Jan 21, 2026	65.14	67.13	64.61	67.00	539.21K
Jan 20, 2026	64.92	66.21	63.97	64.77	362.18K
Jan 16, 2026	65.66	66.09	64.51	65.12	351.36K
Jan 15, 2026	64.70	65.99	64.34	65.61	329.02K
Jan 14, 2026	64.67	65.52	64.36	64.79	273.49K
Jan 13, 2026	65.09	65.90	64.10	64.70	258.76K
Jan 12, 2026	64.69	66.25	64.47	65.30	365.5K
Jan 09, 2026	64.00	64.63	62.89	64.17	255.12K
Jan 08, 2026	62.42	64.50	62.42	63.96	202.87K

Contact Details

Tarrytown, NY 10591

United States

https://www.prestigebrands.com 914 524 6800

About Company

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Stock Peers

MCK

135.8+16.52%

McKesson Corporation$957.80 COR

22.19+6.72%

Cencora, Inc.$352.16 CAH

20.33+9.83%

Cardinal Health, Inc.$227.18 ABC

-0.41-0.23%

AmerisourceBergen Corporation$179.98 GRDN

1.43+4.55%

Guardian Pharmacy Services, Inc.$32.87 OMI

0.22+8.94%

Owens & Minor, Inc.$2.68 ACH

-0.12-5.17%

Accendra Health, Inc.$2.20

Company Overview

Prestige Consumer Healthcare Inc. (NYSE:PBH) closed at $65.55 USD, losing -$1.48 (-2.21%) from the previous close of $67.03. The stock is currently mid-range between its 52-week high and low $57.25 and $90.04. With a market capitalization of about $3.15 billion, Prestige Consumer Healthcare Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.43). Key stats such as the average daily volume over the past year has been around 417.16 thousand shares, in line with its 52-week average. Headquartered in Tarrytown, NY, Prestige Consumer Healthcare Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Ronald Lombardi, the company employs approximately 600 people and listed since February 10, 2005. Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 0.65%, SMA50 4.4%, SMA200 -6.1%). The stock’s 14-day RSI is 54.52 (neutral), while the ATR of 2.06 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -27.2% below its high and over 14.5% above its low. Average 10-day trading volume of 445.41 thousand shares is in line with the 3-month average of 407.91 thousand, indicating normal recent market interest.

Valuation Metrics

Prestige Consumer Healthcare Inc. trades at a P/E ratio of 15.94, slightly below the S&P 500 average, with a price-to-sales ratio of 2.89 and a price-to-book ratio of 1.75 suggesting the stock is closer to book value. The P/FCF stands at 12.58, also above market averages.

Dividend & Fair Value

Prestige Consumer Healthcare Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $187.18. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Prestige Consumer Healthcare Inc. generated EPS of $4.03 over the past year. Five-year average earnings growth is 9.02%. Wall Street analysts project EPS growth of 3.52% annually over the next five years. The latest quarter delivered EPS of $0.86. The next quarter is forecast at $1.14. Next year's EPS is expected at $7.69. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 4 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $104.00 to $66.00. The high target offers 58.66% upside. The low target suggests 0.69% downside. The mean target is $87.89. This offers 34.08% upside. Prestige Consumer Healthcare Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by -11.65%. The prior quarter beat by -5.94%. Over the last six quarters, Apple has recorded several small beats. These include 12.18% in August 08, 2024.

Shareholding & Insider Activity

Prestige Consumer Healthcare Inc. has 49.21 million shares outstanding. The public float is 48.65 million shares, elevated short interest at 3.48% of float. This equals 1.23 million shares. The short ratio is 2.41 days. Institutional investors hold 109.27% of the float. Insiders own 1.26%. Lombardi Ronald M. holds 320.95 thousand shares, Parkinson John has 64.21 thousand shares and MIGAKI PAUL has 55.93 thousand shares. Over the past six months, insider transactions show net selling. They sold 4.00 thousand shares across 3 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Prestige Consumer Healthcare generated $1.14B in revenue, or $22.72 per share. Gross margin was 55.76%, operating margin 29.60%, and net profit margin 18.86%. Returns are healthy, with ROA at 6.31% and ROE at 11.70%.
On valuation metrics, Prestige Consumer Healthcare trades at a P/E of 15.94, P/S of 2.89 and P/B of 1.75. The current ratio is 3.70 and quick ratio is 2.51. Operationally, the company’s inventory turnover is 3.05 and cash conversion cycle is 153.55 days. Debt-to-equity is 0.57, supported by a cash flow-to-debt ratio of 0.25.

Quarterly Financial Highlights

For the quarter ended Mar 31, 2025, Prestige Consumer Healthcare posted revenue of $1.14B, down slightly from $1.13B in the prior quarter. Gross profit was $634.46M (margin 55.76%). Operating income was $336.78M (margin 29.6%). Net income was$214.61M (EPS $4.32).
The company ended the quarter with $97.88M in cash and short-term investments, a total debt of $1.04B, and net debt of $946.37M. Total assets were $3.40B, with equity of $1.83B. Financials further reflected stability, with operating cash flow of $251.52M, free cash flow of $243.29M, and capital expenditures of - $8.22M.

Price Forecast & Outlook

Our AI price prediction model suggests that Prestige Consumer Healthcare Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.74%, with price expected at $64.41 by February 19, 2026, within a range of $63.22 to $65.59 3-Month Outlook: Projected rise of 40.88%, reaching $92.35 by May 06, 2026, with a range of $89.90 to $94.68. 1-Year Outlook: Projected gain of 9.31%, with price at $71.65 by February 05, 2027, within a range of $68.38 to $74.76.

Key Takeaways

Prestige Consumer Healthcare Inc. (NYSE:PBH) shares are flat 4.99% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Prestige Consumer Healthcare Inc. trading at a premium to the broader market with a P/E of 15.94. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $76.32, suggesting 16.43% upside. Our AI forecast model points to short-term weakness (-1.74% over two weeks), a medium-term rise (40.88% over three months), and a longer-term gain (9.31% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Prestige Consumer Healthcare Inc. (PBH) stock price?

Prestige Consumer Healthcare Inc. (NYSE: PBH) stock price is $65.55 in the last trading session. During the trading session, PBH stock reached the peak price of $68.62 while $63.70 was the lowest point it dropped to. The percentage change in PBH stock occurred in the recent session was -2.21% while the dollar amount for the price change in PBH stock was - $1.48.

PBH's industry and sector of operation?

The NYSE listed PBH is part of Medical - Distribution industry that operates in the broader Healthcare sector. Prestige Consumer Healthcare Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PBH?

Ms. Christine Sacco
Chief Financial Officer
Mr. Adel Mekhail
Executive Vice President of Marketing & Sales
Ms. Mary Beth Fritz
Senior Vice President of Quality & Regulatory Affairs
Mr. Ronald M. Lombardi
Chairman, Pres & Chief Executive Officer
Mr. Philip David Terpolilli
Director of Investor Relations
Mr. William C. P'Pool
Senior Vice President, Gen. Counsel & Corporation Sec.
Mr. Jeffrey Zerillo
Senior Vice President of Operations
Dean Siegal
Director of Communications

How PBH did perform over past 52-week?

PBH's closing price is 14.5% higher than its 52-week low of $57.25 where as its distance from 52-week high of $90.04 is -27.2%.

How many employees does PBH have?

Number of PBH employees currently stands at 600.

Link for PBH official website?

Official Website of PBH is: https://www.prestigebrands.com

How do I contact PBH?

PBH could be contacted at phone 914 524 6800 and can also be accessed through its website. PBH operates from 660 White Plains Road, Tarrytown, NY 10591, United States.

How many shares of PBH are traded daily?

PBH stock volume for the day was 560.88K shares. The average number of PBH shares traded daily for last 3 months was 417.16K.

What is the market cap of PBH currently?

The market value of PBH currently stands at $3.15B with its latest stock price at $65.55 and 48.08M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	600
Beta	0.4
Sales or Revenue	$1.14B
5Y Sales Change%	0.206%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Medical - Distribution

PBH Company Profile and Key Details

Prestige Consumer Healthcare

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways